Two-Year Trial Shows Diet Drinks Match Water for Weight Loss and Metabolic Health
A 493-person RCT finds diet sodas rival water for long-term weight loss, with no appetite disruption or metabolic harm detected.
Summary
A two-year randomized controlled trial from the University of Liverpool tested whether diet drinks sweetened with aspartame, acesulfame-K, or sucralose perform as well as water for weight management. The SWITCH trial enrolled 493 adults with overweight or obesity in a structured behavioral program. After 104 weeks, both groups lost similar amounts of weight and showed improvements in waist circumference, body composition, and metabolic biomarkers. No meaningful differences in blood pressure, cholesterol, or appetite regulation were found between the groups. The results challenge WHO guidance discouraging non-sugar sweeteners for weight control and provide the longest randomized clinical evidence to date on this topic, offering practical reassurance for adults using diet drinks as part of a calorie-reduction strategy.
Detailed Summary
Non-nutritive sweetened beverages are among the most widely consumed dietary substitutes worldwide, yet their long-term safety and effectiveness for weight management have remained controversial. Observational studies have raised concerns about appetite stimulation and metabolic disruption, leading the WHO to caution against their use for weight control. The SWITCH trial was designed to provide high-quality randomized evidence to settle these questions.
The trial enrolled 493 adults with overweight or obesity and randomly assigned them to drink either plain water or commercially available diet beverages daily over 104 weeks — making it among the longest RCTs on this question. Both groups participated in a structured behavioral weight management program for the first year, then continued independently in the second year.
After two years, weight loss was similar between the diet-drink group and the water group, at 4.8 kg versus 3.7 kg respectively — a difference that was not statistically significant. Both groups also saw reductions in waist and hip circumference, improvements in body composition, and favorable shifts in several metabolic biomarkers. Sugar intake declined in both groups, with a slightly larger reduction among those drinking diet beverages. No clinically meaningful differences in blood pressure or cholesterol were linked to sweetener consumption.
These findings directly counter the hypothesis that non-nutritive sweeteners stimulate appetite or cause long-term metabolic harm. For adults trying to reduce calorie intake or transition away from sugar-sweetened beverages, the data suggest diet drinks are a viable tool rather than a hidden liability.
Key caveats deserve attention. The study was funded by the American Beverage Association, though researchers report full analytical independence. Sweetener doses stayed within EFSA safety limits, so findings may not apply to very high consumption. Additionally, the behavioral program itself drove much of the weight loss, making it harder to isolate the effect of the beverages alone.
Key Findings
- Diet drinks and water produced statistically similar weight loss (~4.8 kg vs ~3.7 kg) over 104 weeks in adults with obesity.
- Both groups improved waist circumference, body composition, and metabolic biomarkers equally after two years.
- No evidence of increased appetite or metabolic harm linked to aspartame, acesulfame-K, or sucralose was detected.
- Sugar intake fell slightly more in diet-drink users, suggesting a useful substitution effect for reducing overall sugar consumption.
- Results challenge WHO guidance against non-sugar sweeteners and provide the longest RCT evidence on this topic to date.
Methodology
This is a research summary reporting results from the SWITCH trial, a 104-week randomized controlled trial published in the British Journal of Nutrition. The study enrolled 493 adults and was led by researchers at the University of Liverpool; it represents high-quality clinical evidence. A notable limitation is industry funding from the American Beverage Association, though independent analysis is claimed.
Study Limitations
Industry funding from the American Beverage Association introduces potential bias, despite reported researcher independence. Sweetener intakes were kept within EFSA safety thresholds, so findings may not generalize to very high consumption levels. The behavioral support program was a major confound, making it difficult to attribute outcomes to beverage type alone.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: